On September 2, 2020 Humanigen, Inc., (HGEN) ("Humanigen"), reported that Cameron Durrant, MD, MBA, Chief Executive Officer, Dale Chappell, MD, MBA, Chief Scientific Officer, and Timothy Morris, Chief Operating and Financial Officer of Humanigen will present company overviews and business updates at the following upcoming investor conferences (Press release, Humanigen, SEP 2, 2020, View Source [SID1234564336]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

LD Micro 500 Conference at 2:20 p.m. on Thursday, September 3, 2020
Baird’s 2020 Global Healthcare Conference at 3:45 p.m. on Wednesday, September 9, 2020
H.C. Wainwright 22nd Annual Global Investment Conference at 9:30 a.m. ET on Wednesday, September 16, 2020
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit at 10:50 a.m. on Wednesday, September 23, 2020
The conferences are being held in a virtual format. Webcast information for these events will be available on the Humanigen’s investor page at View Source Archived replays will be available on the Company website for 30 days following each event.